HHS Launches
President Trump’s ‘Advancing American Kidney Health’ Initiative
Today,
President Donald Trump signed an Executive Order to launch Advancing American Kidney Health ,
a bold new initiative to improve the lives of Americans suffering
from kidney disease, expand options for American patients, and
reduce healthcare costs. The initiative provides specific solutions
to deliver on three goals: fewer patients developing kidney
failure, fewer Americans receiving dialysis in dialysis centers,
and more kidneys available for transplant.
As directed by the Executive Order, the U.S.
Department of Health and Human Services (HHS) announced today that
the Centers for Medicare & Medicaid Services (CMS), through its
Center for Medicare and Medicaid Innovation (CMMI), released a
proposed required payment model and four optional payment models to
adjust payment incentives to encourage preventative kidney care,
home dialysis, and kidney transplants. The Department’s Assistant
Secretary for Planning and Evaluation (ASPE) also released a paper
entitled Advancing American
Kidney Health , which lays out a number of areas for action,
including measures called for in the executive order, for various
components of HHS to improve kidney care.
“President Trump is tackling the toughest issues in
American healthcare, and few areas need reform more than the way we
treat kidney disease,” said HHS Secretary Alex Azar. “Decades of
paying for sickness and procedures in kidney care, rather than
paying for health and outcomes, has produced less-than-satisfactory
outcomes at tremendous cost. Through new payment models and many
other actions under this initiative, the Trump Administration will
transform this situation and deliver Americans better kidney
health, more kidney treatment options, and more transplants.”
Across America, 37 million patients suffer from
chronic kidney disease and more than 726,000 have end-stage renal
disease (ESRD). There are nearly 100,000 Americans waiting on the
list to receive a kidney transplant, and kidney disease ranks as
the ninth leading cause of death in America.
Approximately twenty percent of dollars in traditional
Medicare—$114 billion a year—are spent on Americans with kidney
disease. Yet of the more than 100,000 American who begin dialysis
to treat end-stage renal disease each year, one in five will die
within a year. HHS has laid out three goals for improving kidney
health:
1. Reducing the
number of Americans developing end-stage renal disease by 25
percent by 2030
2. Having 80
percent of new ESRD patients in 2025 either receiving dialysis at
home or receiving a transplant
3. Doubling the
number of kidneys available for transplant by 2030
This week, HHS is taking a number of immediate actions
toward these goals. To reduce the development of end-stage renal
disease, CMMI released a set of four optional payment models,
expected to enroll more than 200,000 Medicare patients in
arrangements that give providers new incentives for preventing
kidney disease and managing kidney patients’ health in a more
comprehensive and person-centered way.
To provide more options for people with kidney
failure, CMMI also announced a required payment model, known as
ESRD Treatment Choices, which will enroll all dialysis providers in
approximately half of the country and provide new incentives to
encourage dialysis in the home.
To enhance patient access to transplantable organs,
all five new payment models will give providers new incentives to
help eligible patients receive transplants.
The President’s Executive Order also calls for HHS to:
·
Launch a public awareness campaign to increase
knowledge of chronic kidney disease, which 40 percent of American
patients do not know they have
·
Reform the organ procurement and management system in
the United States to significantly increase the supply of
transplantable kidneys
·
Expand support for living donors through compensation
for costs such as lost wages and child care expenses
·
Encourage development of wearable or implantable
artificial kidneys, through cooperation between developers and the
Food and Drug Administration (FDA) and support for KidneyX,
a public-private partnership between HHS and the American
Society of Nephrology
As laid out in the ASPE paper, Advancing American Kidney Health,
HHS will also, among other measures:
·
Improve Centers for Disease Control and Prevention
(CDC) work on tracking and detecting chronic kidney disease
throughout the population and supporting state and local efforts to
develop a public health response for people with key risk factors
·
Expand work to study and implement evidence-based
approaches to preventing kidney disease through CDC and the
National Institutes of Health
·
Support work on portable dialysis options through the
Assistant Secretary for Preparedness and Response to ensure
individuals who need dialysis have ready access to treatment in the
aftermath of disaster situations
·
Inform development of new kidney disease treatments
that align with patient preferences, including alternatives to
dialysis, through patient surveys being developed by the FDA
·
Examine ways to improve CMS’s ESRD payment policies
·
Continue research work through NIH to advance
precision medicine for kidney disease
·
Launch additional prize competitions through KidneyX
to support the development of new tools for preventing, managing,
and treating kidney disease
·
Work further toward reducing disparities in
performance among Organ Procurement Organizations (OPOs) and
transplant centers with the goal of increasing recovery of kidneys
by OPOs and utilization of kidneys by transplant centers.
* People using assistive technology may not be able to
fully access information in this file. For assistance, contact digital@hhs.gov.
###
|
No comments:
Post a Comment